Qingsong Pang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Medical University Cancer Institute and Hospital, National Cancer Center · ORCID：0000-0002-3576-6909

发表论文 194 篇 · 总被引 3385 次 · h-index 27

代表论文

• Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (2024 · Insights into Imaging · 被引 22)
• Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial (2024 · Nature Communications · 被引 22)
• Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy (2024 · Cancer Medicine · 被引 15)
• Neoadjuvant Immunochemoradiation Therapy Versus Chemoradiation Therapy in Esophageal Cancer: A Systematic Review and Meta-Analysis of Reconstructed Individual Patient Data (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 10)
• Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial (2025 · BMC Cancer · 被引 6)
• Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma (2025 · Strahlentherapie und Onkologie · 被引 5)